These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26743935)

  • 21. Cysteine proteases as targets for metal-based drugs.
    Fricker SP
    Metallomics; 2010 Jun; 2(6):366-77. PubMed ID: 21072382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the mechanism of action and cellular targets of ruthenium complexes from NMR spectroscopy.
    Giannini F; Paul LE; Furrer J
    Chimia (Aarau); 2012; 66(10):775-80. PubMed ID: 23146264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antileukemic activity and cellular effects of rhodium(III) crown thiaether complexes.
    Bieda R; Kitanovic I; Alborzinia H; Meyer A; Ott I; Wölfl S; Sheldrick WS
    Biometals; 2011 Aug; 24(4):645-61. PubMed ID: 21274738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detecting DNA mismatches with metallo-insertors: a molecular simulation study.
    Vargiu AV; Magistrato A
    Inorg Chem; 2012 Feb; 51(4):2046-57. PubMed ID: 22288501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speciation of Metal Complexes of Medicinal Interest: Relationship between Solution Equilibria and Pharmaceutical Properties.
    Kiss T; Enyedy ÉA; Jakusch T; Dömötör O
    Curr Med Chem; 2019; 26(4):580-606. PubMed ID: 29521198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rhodium(I) N-Heterocyclic Carbene Bioorganometallics as in Vitro Antiproliferative Agents with Distinct Effects on Cellular Signaling.
    Oehninger L; Spreckelmeyer S; Holenya P; Meier SM; Can S; Alborzinia H; Schur J; Keppler BK; Wölfl S; Ott I
    J Med Chem; 2015 Dec; 58(24):9591-600. PubMed ID: 26595649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyamine quinoline rhodium complexes: synthesis and pharmacological evaluation as antiparasitic agents against Plasmodium falciparum and Trichomonas vaginalis.
    Stringer T; Taylor D; Guzgay H; Shokar A; Au A; Smith PJ; Hendricks DT; Land KM; Egan TJ; Smith GS
    Dalton Trans; 2015 Sep; 44(33):14906-17. PubMed ID: 26226082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technologies to develop new metal medicines.
    Dufrasne F
    Drug Discov Today Technol; 2015 Sep; 16():31-2. PubMed ID: 26547419
    [No Abstract]   [Full Text] [Related]  

  • 29. Photocatalytic production of hydrogen by disproportionation of one-electron-reduced rhodium and iridium-ruthenium complexes in water.
    Fukuzumi S; Kobayashi T; Suenobu T
    Angew Chem Int Ed Engl; 2011 Jan; 50(3):728-31. PubMed ID: 21226164
    [No Abstract]   [Full Text] [Related]  

  • 30. The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani.
    Croft SL; Neal RA; Craciunescu DG; Certad-Fombona G
    Trop Med Parasitol; 1992 Mar; 43(1):24-8. PubMed ID: 1598504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal activity of rhodium, iridium, and ruthenium tripodal phosphine complexes.
    Sülü M; Küçükbay H; Durmaz R; Günal S
    New Microbiol; 2000 Jan; 23(1):73-8. PubMed ID: 10946408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity.
    Dömötör O; Aicher S; Schmidlehner M; Novak MS; Roller A; Jakupec MA; Kandioller W; Hartinger CG; Keppler BK; Enyedy ÉA
    J Inorg Biochem; 2014 May; 134():57-65. PubMed ID: 24556426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes.
    Singh SK; Joshi S; Singh AR; Saxena JK; Pandey DS
    Inorg Chem; 2007 Dec; 46(25):10869-76. PubMed ID: 18001110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal-ligand binding interactions in rhodium/palladium-catalyzed synthesis of dihydroquinolines.
    Zhang L; Panteleev J; Lautens M
    J Org Chem; 2014 Dec; 79(24):12159-76. PubMed ID: 25337795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cobalt derivatives as promising therapeutic agents.
    Heffern MC; Yamamoto N; Holbrook RJ; Eckermann AL; Meade TJ
    Curr Opin Chem Biol; 2013 Apr; 17(2):189-96. PubMed ID: 23270779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspective: the potential of pyrazole-based compounds in medicine.
    Keter FK; Darkwa J
    Biometals; 2012 Feb; 25(1):9-21. PubMed ID: 22002344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells.
    Hackenberg F; Oehninger L; Alborzinia H; Can S; Kitanovic I; Geldmacher Y; Kokoschka M; Wölfl S; Ott I; Sheldrick WS
    J Inorg Biochem; 2011 Jul; 105(7):991-9. PubMed ID: 21569751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trapping unstable benzoquinone analogues by coordination to a [(η(5)-C(5)Me(5))Ir] fragment and the anticancer activity of the resulting complexes.
    Hartinger CG
    Angew Chem Int Ed Engl; 2010 Nov; 49(45):8304-5. PubMed ID: 20803595
    [No Abstract]   [Full Text] [Related]  

  • 40. Antagonizing STAT3 dimerization with a rhodium(III) complex.
    Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH
    Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.